FDA Approvals And Changes For The Week Ending February 14, 2014

By: via Benzinga
The week ending February 14 was a nightmare for the Food and Drug Administration, as numerous companies sought not only manufacturing changes, but drug approvals as well. Below are some of the more notable changes and approvals. February 13: Some companies that sought after manufacturing changes include: Amylin (NASDAQ:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.